Skip to main content

Table 2 Comparison of PET and CT response by dose cohort.

From: The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study

Dose

Initial Response

CR

PR

SD

PD

Non-measurable

CT

PET

CT

PET

CT

PET

CT

PET

CT

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

24 Gy (n=19)

4 (24%)

14 (74%)

8 (47%)

4 (21%)

4 (24%)

0

1 (6%)

1 (5%)

2 (11%)

30 Gy (n=20)

3 (21%)

12 (60%)

3 (21%)

7 (35%)

8 (57%)

1 (5%)

0

0

6 (30%)

36 Gy (n=8)

1 (14%)

4 (50%)

1 (14%)

4 (50%)

5 (71%)

0

0

0

1 (13%)

42 Gy (n=9)

1 (14%)

5 (55%)

2 (29%)

4 (44%)

5 (71%)

0

0

0

1 (13%)

50 Gy (n=2)

0

0

2 (100%)

2 (100%)

0

0

0

0

0

Total

9 (19%)

35 (60%)

16 (33%)

21 (36%)

22 (46%)

1 (2%)

1 (2%)

1 (2%)

10 (17%)

  1. CR complete response.
  2. Gy gray.
  3. PR partial response.
  4. PD progressive disease.
  5. SD stable disease.